{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:50:28Z","timestamp":1760161828136,"version":"build-2065373602"},"reference-count":45,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant mesothelioma (MM) is an aggressive tumor of the serosal cavities. Angiogenesis is important for mesothelioma progression, but so far, anti-angiogenic agents have not improved patient survival. Our hypothesis is that better understanding of the regulation of angiogenesis in this tumor would largely improve the success of such a therapy. Syndecan-1 (SDC-1) is a transmembrane heparan sulfate proteoglycan that acts as a co-receptor in various cellular processes including angiogenesis. In MM, the expression of SDC-1 is generally low but when present, SDC-1 associates to epithelioid differentiation, inhibition of tumor cell migration and favorable prognosis, meanwhile SDC-1 decrease deteriorates the prognosis. In the present study, we studied the effect of SDC-1 overexpression and silencing on MM cells ability to secrete angiogenic factors and monitored the downstream effect of SDC-1 modulation on endothelial cells proliferation, wound healing, and tube formation. This was done by adding conditioned medium from SDC-1 transfected and SDC-1 silenced mesothelioma cells to endothelial cells. Moreover, we investigated the interplay and molecular functional changes in angiogenesis in a co-culture system and characterized the soluble angiogenesis-related factors secreted to the conditioned media. We demonstrated that SDC-1 over-expression inhibited the proliferation, wound healing, and tube formation of endothelial cells. This effect was mediated by a multitude of angiogenic factors comprising angiopoietin-1 (Fold change \u00b1 SD: 0.65 \u00b1 0.07), FGF-4 (1.45 \u00b1 0.04), HGF (1.33 \u00b1 0.07), NRG1-\u03b21 (1.35 \u00b1 0.08), TSP-1 (0.8 \u00b1 0.02), TIMP-1 (0.89 \u00b1 0.01) and TGF-\u03b21 (1.35 \u00b1 0.01). SDC-1 silencing increased IL8 (1.33 \u00b1 0.06), promoted wound closure, but did not influence the tube formation of endothelial cells. Pleural effusions from mesothelioma patients showed that Vascular Endothelial Growth Factor (VEGF) levels correlate to soluble SDC-1 levels and have prognostic value. In conclusion, SDC-1 over-expression affects the angiogenic factor secretion of mesothelioma cells and thereby inhibits endothelial cells proliferation, tube formation, and wound healing. VEGF could be used in prognostic evaluation of mesothelioma patients together with SDC-1.<\/jats:p>","DOI":"10.3390\/cancers13040655","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T20:51:51Z","timestamp":1612817511000},"page":"655","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells"],"prefix":"10.3390","volume":"13","author":[{"given":"Joman","family":"Javadi","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, SE-14157 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazal","family":"Heidari-Hamedani","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, SE-14157 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-1318","authenticated-orcid":false,"given":"Angelika","family":"Schmalzl","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, SE-14157 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fcnde","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, SE-14157 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Metintas","sequence":"additional","affiliation":[{"name":"Department of Chest, Eskisehir Osmangazi University Medical Faculty, 26040 Eskisehir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-7381","authenticated-orcid":false,"given":"Pontus","family":"Aspenstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University Rubeck Laboratory, SE-75185 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hjerpe","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, SE-14157 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Dobra","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, SE-14157 Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: Facts, Myths, and Hypotheses","volume":"227","author":"Carbone","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1586\/17476348.2015.1081066","article-title":"Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies","volume":"9","author":"Bononi","year":"2015","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_3","first-page":"1164","article-title":"Malignant pleural mesothelioma: Factors influencing the prognosis","volume":"26","author":"Mineo","year":"2012","journal-title":"Oncology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.2042-7158.2011.01352.x","article-title":"Methods for co-culturing tumour and endothelial cells: Systems and their applications","volume":"63","author":"Dass","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_5","first-page":"751","article-title":"Mechanisms of angiogenesis","volume":"73","author":"Karamysheva","year":"2008","journal-title":"Biochemistry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s004280050388","article-title":"Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma","volume":"435","author":"Tolnay","year":"1999","journal-title":"Virchows. Archiv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<211::AID-PATH834>3.0.CO;2-D","article-title":"Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma","volume":"182","author":"Vermeulen","year":"1997","journal-title":"J. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0","article-title":"Angiogenic cytokines in mesothelioma: A study of VEGF, FGF-1 and -2, and TGF? expression","volume":"189","author":"Weyler","year":"1999","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2017.72.9012","article-title":"Nintedanib Plus Pemetrexed\/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial","volume":"35","author":"Grosso","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2184.2009.00651.x","article-title":"Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains","volume":"43","author":"Zong","year":"2009","journal-title":"Cell Prolif."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Szatm\u00e1ri, T., Mundt, F., Heidari-Hamedani, G., Zong, F., Ferolla, E., Alexeyenko, A., Hjerpe, A., and Dobra, K. (2012). Novel Genes and Pathways Modulated by Syndecan-1: Implications for the Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048091"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2011.10.001","article-title":"Molecular functions of syndecan-1 in disease","volume":"31","author":"Teng","year":"2012","journal-title":"Matrix Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/febs.12160","article-title":"Synstatin: A selective inhibitor of the syndecan-1-coupled IGF1R-\u03b1v\u03b23 integrin complex in tumorigenesis and angiogenesis","volume":"280","author":"Rapraeger","year":"2013","journal-title":"FEBS J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/wound.2014.0555","article-title":"Syndecan-1 and Its Expanding List of Contacts","volume":"4","author":"Stepp","year":"2015","journal-title":"Adv. Wound Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.cellsig.2009.05.001","article-title":"Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion","volume":"21","author":"Mythreye","year":"2009","journal-title":"Cell Sign."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q","article-title":"Syndecan-1 expression in malignant mesothelioma: Correlation with cell differentiation, WT1 expression, and clinical outcome","volume":"186","author":"Jacobs","year":"1998","journal-title":"J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/419853","article-title":"Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies","volume":"2014","author":"Mundt","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zong, F., Fthenou, E., Mundt, F., Szatm\u00e1ri, T., Kovalszky, I., Szil\u00e1k, L., Brodin, D., Tzanakakis, G., Hjerpe, A., and Dobra, K. (2011). Specific Syndecan-1 Domains Regulate Mesenchymal Tumor Cell Adhesion, Motility and Migration. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0014816"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The Hallmarks of Cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00046358","article-title":"Endothelial-Cells and Angiogenic Growth-Factors in Cancer Growth and Metastasis\u2014Introduction","volume":"9","author":"Folkman","year":"1990","journal-title":"Cancer Metastasis Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Medical progress\u2014Advances in Malignant Mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ijc.10996","article-title":"Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops","volume":"104","author":"Masood","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/14767058.2013.830411","article-title":"In search of biomarkers for diagnosing and managing neonatal sepsis: The role of angiopoietins","volume":"26","author":"Mussap","year":"2013","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_26","first-page":"70","article-title":"Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation","volume":"376","author":"Sato","year":"1995","journal-title":"Nat. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1183\/09031936.00154009","article-title":"A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma","volume":"36","author":"Tabata","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/07357907.2013.830734","article-title":"Clinical Significance of Serum Angiopoietin-1 in Malignant Peritoneal Mesothelioma","volume":"31","author":"Mikami","year":"2013","journal-title":"Cancer Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2570::AID-CNCR12>3.0.CO;2-F","article-title":"Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma","volume":"85","author":"Ohta","year":"1999","journal-title":"Cancer"},{"key":"ref_30","first-page":"H2205","article-title":"Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis","volume":"277","author":"Russell","year":"1999","journal-title":"Am. J. Physiol. Content"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1074\/mcp.M113.030775","article-title":"Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma","volume":"13","author":"Mundt","year":"2014","journal-title":"Mol. Cell. Proteom."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00018-013-1457-3","article-title":"Cytokine functions of TIMP-1","volume":"71","author":"Ries","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1083\/jcb.119.3.629","article-title":"Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth","volume":"119","author":"Bussolino","year":"1992","journal-title":"J. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/BST20150252","article-title":"The role of the HGF\/Met axis in mesothelioma","volume":"44","author":"Thayaparan","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1096\/fj.02-0377fje","article-title":"Fibroblast growth factor-4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model","volume":"17","author":"Rissanen","year":"2002","journal-title":"FASEB J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/ijmm.2013.1444","article-title":"Therapeutics targeting angiogenesis: Genetics and epigenetics, extracellular miRNAs and signaling networks (Review)","volume":"32","author":"Katoh","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/excr.1993.1043","article-title":"Biphasic Effect of Transforming Growth Factor-\u03b21 on in Vitro Angiogenesis","volume":"204","author":"Pepper","year":"1993","journal-title":"Exp. Cell Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Chen, P., Abacherli, L.E., Nadler, S.T., Wang, Y., Li, Q., and Parks, W.C. (2009). MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting \u03b12\u03b21 Integrin Activation. PLOS ONE, 4.","DOI":"10.1371\/journal.pone.0006565"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.lungcan.2016.01.020","article-title":"Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma","volume":"94","author":"Comar","year":"2016","journal-title":"Lung Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/JTO.0b013e3181d2f008","article-title":"Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma","volume":"5","author":"Yasumitsu","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_41","first-page":"137","article-title":"Pleural Effusion VEGF Levels As A Prognostic Factor Of Malignant Pleural Mesothelioma","volume":"105","author":"Hirayama","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/bjc.2014.493","article-title":"Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer","volume":"111","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2009-07-234757","article-title":"Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis","volume":"115","author":"Purushothaman","year":"2010","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2014.12.003","article-title":"Advances in the molecular functions of syndecan-1 (SDC1\/CD138) in the pathogenesis of malignancies","volume":"94","author":"Gharbaran","year":"2015","journal-title":"Crit. Rev. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.matbio.2013.10.005","article-title":"Chemotherapy stimulates syndecan-1 shedding: A potentially negative effect of treatment that may promote tumor relapse","volume":"35","author":"Ramani","year":"2014","journal-title":"Matrix Biol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/4\/655\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:20:36Z","timestamp":1760160036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/4\/655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,6]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["cancers13040655"],"URL":"https:\/\/doi.org\/10.3390\/cancers13040655","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2021,2,6]]}}}